Skip to main content
Erschienen in: European Radiology 9/2012

01.09.2012 | Interventional

MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions

verfasst von: Hansjörg Rempp, Lorenz Waibel, Rüdiger Hoffmann, Claus D. Claussen, Philippe L. Pereira, Stephan Clasen

Erschienen in: European Radiology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the technical effectiveness, technical success and patient safety of MR-guided radiofrequency (RF) ablation of liver malignancies using a wide-bore 1.5-T MR system.

Methods

In 110 patients, 56 primary liver lesions and 157 liver metastases were treated in 157 sessions using percutaneous RF ablation. Mean lesion diameter was 20 mm (range 4–54 mm). All planning, procedural and post-interventional control MR investigations were carried out using a wide-bore 1.5-T MR system. Technical success was assessed by a contrast-enhanced MR liver examination immediately after the intervention. Technique effectiveness was assessed by dynamic hepatic MR study 1 month post ablation; mean follow-up period was 24.2 months (range 5–44).

Results

Technical success and technique effectiveness were achieved in 210/213 lesions (98.6 %). In 18/210 lesions (8.6 %), local tumour progression occurred 4–28 months after therapy. Seven of these 18 lesions were treated in a second session achieving complete ablation, 6 other lesions were referred to surgery. Overall RF effectiveness rate was 199/213 (93.4 %); overall therapy success (including surgery) was 205/213 (96.2 %). Two major complications (1.3 %) (bleeding and infected biloma) and 14 (8.9 %) minor complications occurred subsequent to 157 interventions.

Conclusion

Wide-bore MR-guided RF ablation is a safe and effective treatment option for liver lesions.

Key Points

Magnetic resonance-guided radiofrequency ablation offers various options for monitoring therapy.
All steps of RF ablation carried out in 1.5-T wide-bore system.
Therapeutic decisions were based on T1-weighted imaging.
Technical success and technical effectiveness were high.
Local tumour progression rate was 8.6 % over a 24-month mean follow-up.
Literatur
1.
Zurück zum Zitat Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967PubMedCrossRef Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967PubMedCrossRef
2.
Zurück zum Zitat Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206–1213PubMedCrossRef Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206–1213PubMedCrossRef
3.
Zurück zum Zitat Goldberg SN, Ahmed M (2002) Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 35:S115–S129PubMedCrossRef Goldberg SN, Ahmed M (2002) Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 35:S115–S129PubMedCrossRef
4.
Zurück zum Zitat Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166PubMedCrossRef Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166PubMedCrossRef
5.
Zurück zum Zitat Bonastre J, De Baere T, Elias D et al (2007) Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroenterol Clin Biol 31:828–835PubMedCrossRef Bonastre J, De Baere T, Elias D et al (2007) Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroenterol Clin Biol 31:828–835PubMedCrossRef
6.
Zurück zum Zitat Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef
7.
8.
Zurück zum Zitat Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78(Suppl 1):113–124PubMedCrossRef Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78(Suppl 1):113–124PubMedCrossRef
9.
Zurück zum Zitat Lee WS, Yun SH, Chun HK et al (2008) Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 42:945–949PubMedCrossRef Lee WS, Yun SH, Chun HK et al (2008) Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 42:945–949PubMedCrossRef
10.
Zurück zum Zitat Aloia TA, Vauthey JN, Loyer EM et al (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460–466, discussion 466–467PubMedCrossRef Aloia TA, Vauthey JN, Loyer EM et al (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460–466, discussion 466–467PubMedCrossRef
11.
Zurück zum Zitat de Baere T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed de Baere T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed
12.
Zurück zum Zitat Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15:144–157PubMedCrossRef Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15:144–157PubMedCrossRef
13.
Zurück zum Zitat Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156PubMedCrossRef Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156PubMedCrossRef
14.
Zurück zum Zitat Machi J, Bueno RS, Wong LL (2005) Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 29:1364–1373PubMedCrossRef Machi J, Bueno RS, Wong LL (2005) Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 29:1364–1373PubMedCrossRef
15.
Zurück zum Zitat Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171PubMedCrossRef Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171PubMedCrossRef
16.
Zurück zum Zitat Leyendecker JR, Dodd GD 3rd, Halff GA et al (2002) Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 178:1147–1151PubMed Leyendecker JR, Dodd GD 3rd, Halff GA et al (2002) Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 178:1147–1151PubMed
17.
Zurück zum Zitat Pacella CM, Bizzarri G, Anelli V et al (1998) Evaluation of the vascular pattern of hepatocellular carcinoma with dynamic computed tomography and its use in identifying optimal temporal windows for helical computed tomography. Eur Radiol 8:30–35PubMedCrossRef Pacella CM, Bizzarri G, Anelli V et al (1998) Evaluation of the vascular pattern of hepatocellular carcinoma with dynamic computed tomography and its use in identifying optimal temporal windows for helical computed tomography. Eur Radiol 8:30–35PubMedCrossRef
18.
Zurück zum Zitat Lewin JS, Connell CF, Duerk JL et al (1998) Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 8:40–47PubMedCrossRef Lewin JS, Connell CF, Duerk JL et al (1998) Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 8:40–47PubMedCrossRef
19.
Zurück zum Zitat McDannold N, Jolesz F (2000) Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging 11:191–202PubMedCrossRef McDannold N, Jolesz F (2000) Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging 11:191–202PubMedCrossRef
20.
Zurück zum Zitat Clasen S, Pereira PL (2008) Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging 27:421–433PubMedCrossRef Clasen S, Pereira PL (2008) Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging 27:421–433PubMedCrossRef
21.
Zurück zum Zitat Hindmann JC (1966) Proton resonance shift of water in the gas and liquid state. J Chem Phys 44:4582–4592CrossRef Hindmann JC (1966) Proton resonance shift of water in the gas and liquid state. J Chem Phys 44:4582–4592CrossRef
22.
Zurück zum Zitat Rempp H, Hoffmann R, Roland J et al (2011) Threshold-based prediction of the coagulation zone in sequential temperature mapping in MR-guided radiofrequency ablation of liver tumours. Eur Radiol. doi:10.1007/s00330-011-2335-8 Rempp H, Hoffmann R, Roland J et al (2011) Threshold-based prediction of the coagulation zone in sequential temperature mapping in MR-guided radiofrequency ablation of liver tumours. Eur Radiol. doi:10.​1007/​s00330-011-2335-8
23.
Zurück zum Zitat Rofsky NM, Lee VS, Laub G et al (1999) Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212:876–884PubMed Rofsky NM, Lee VS, Laub G et al (1999) Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212:876–884PubMed
24.
Zurück zum Zitat Lee VS, Lavelle MT, Rofsky NM et al (2000) Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 215:365–372PubMed Lee VS, Lavelle MT, Rofsky NM et al (2000) Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 215:365–372PubMed
25.
Zurück zum Zitat Schraml C, Schwenzer NF, Clasen S et al (2009) Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 29:1308–1316PubMedCrossRef Schraml C, Schwenzer NF, Clasen S et al (2009) Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 29:1308–1316PubMedCrossRef
26.
Zurück zum Zitat Kierans AS, Elazzazi M, Braga L et al (2010) Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. AJR Am J Roentgenol 194:523–529PubMedCrossRef Kierans AS, Elazzazi M, Braga L et al (2010) Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. AJR Am J Roentgenol 194:523–529PubMedCrossRef
27.
Zurück zum Zitat Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–S390PubMedCrossRef Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–S390PubMedCrossRef
28.
Zurück zum Zitat Kelekis AD, Terraz S, Roggan A et al (2003) Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results. Eur Radiol 13:1100–1105PubMed Kelekis AD, Terraz S, Roggan A et al (2003) Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results. Eur Radiol 13:1100–1105PubMed
29.
Zurück zum Zitat Huppert PE, Trubenbach J, Schick F, Pereira P, Konig C, Claussen CD (2000) MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms—first technical and clinical experiences. Rofo 172:692–700PubMedCrossRef Huppert PE, Trubenbach J, Schick F, Pereira P, Konig C, Claussen CD (2000) MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms—first technical and clinical experiences. Rofo 172:692–700PubMedCrossRef
30.
Zurück zum Zitat Kettenbach J, Köstler W, Rücklinger E et al (2003) Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 180:1537–1545PubMed Kettenbach J, Köstler W, Rücklinger E et al (2003) Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 180:1537–1545PubMed
31.
Zurück zum Zitat Mahnken AH, Buecker A, Spuentrup E et al (2004) MR-guided radiofrequency ablation of hepatic malignancies at 1.5T: initial results. J Magn Reson Imaging 19:342–348PubMedCrossRef Mahnken AH, Buecker A, Spuentrup E et al (2004) MR-guided radiofrequency ablation of hepatic malignancies at 1.5T: initial results. J Magn Reson Imaging 19:342–348PubMedCrossRef
32.
Zurück zum Zitat Gaffke G, Gebauer B, Knollmann FD (2006) Use of semiflexible applicators for radiofrequency ablation of liver tumors. Cardiovasc Intervent Radiol 29:270–275PubMedCrossRef Gaffke G, Gebauer B, Knollmann FD (2006) Use of semiflexible applicators for radiofrequency ablation of liver tumors. Cardiovasc Intervent Radiol 29:270–275PubMedCrossRef
33.
Zurück zum Zitat Boss A, Rempp H, Martirosian P et al (2008) Wide-bore 1.5 Tesla MR imagers for guidance and monitoring of radiofrequency ablation of renal cell carcinoma: initial experience on feasibility. Eur Radiol 18:1449–1455PubMedCrossRef Boss A, Rempp H, Martirosian P et al (2008) Wide-bore 1.5 Tesla MR imagers for guidance and monitoring of radiofrequency ablation of renal cell carcinoma: initial experience on feasibility. Eur Radiol 18:1449–1455PubMedCrossRef
34.
Zurück zum Zitat Chen MH, Wei Y, Yan K et al (2006) Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 17:671–683PubMedCrossRef Chen MH, Wei Y, Yan K et al (2006) Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 17:671–683PubMedCrossRef
35.
Zurück zum Zitat Aube C, Schmidt D, Brieger J et al (2004) Magnetic resonance imaging characteristics of six radiofrequency electrodes in a phantom study. J Vasc Interv Radiol 15:385–392PubMedCrossRef Aube C, Schmidt D, Brieger J et al (2004) Magnetic resonance imaging characteristics of six radiofrequency electrodes in a phantom study. J Vasc Interv Radiol 15:385–392PubMedCrossRef
36.
Zurück zum Zitat Bathe OF, Mahallati H (2007) MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid. J Surg Oncol 95:670–673PubMedCrossRef Bathe OF, Mahallati H (2007) MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid. J Surg Oncol 95:670–673PubMedCrossRef
37.
Zurück zum Zitat Fischbach F, Bunke J, Thormann M et al (2011) MR-guided freehand biopsy of liver lesions with fast continuous imaging using a 1.0-T open MRI scanner: experience in 50 patients. Cardiovasc Intervent Radiol 34:188–192PubMedCrossRef Fischbach F, Bunke J, Thormann M et al (2011) MR-guided freehand biopsy of liver lesions with fast continuous imaging using a 1.0-T open MRI scanner: experience in 50 patients. Cardiovasc Intervent Radiol 34:188–192PubMedCrossRef
38.
Zurück zum Zitat Solbiati L, Ierace T, Tonolini M, Cova L (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51(Suppl):S19–S23PubMedCrossRef Solbiati L, Ierace T, Tonolini M, Cova L (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51(Suppl):S19–S23PubMedCrossRef
39.
Zurück zum Zitat Wiggermann P, Zuber-Jerger I, Zausig Y et al (2011) Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: Preliminary results. Clin Hemorheol Microcirc 49:43–54PubMed Wiggermann P, Zuber-Jerger I, Zausig Y et al (2011) Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: Preliminary results. Clin Hemorheol Microcirc 49:43–54PubMed
40.
Zurück zum Zitat Takahashi S, Kudo M, Chung H et al (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72(Suppl 1):98–103PubMedCrossRef Takahashi S, Kudo M, Chung H et al (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72(Suppl 1):98–103PubMedCrossRef
41.
Zurück zum Zitat Clasen S, Rempp H, Boss A et al (2011) MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness. J Vasc Interv Radiol 22:762–770PubMedCrossRef Clasen S, Rempp H, Boss A et al (2011) MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness. J Vasc Interv Radiol 22:762–770PubMedCrossRef
42.
Zurück zum Zitat Clasen S, Boss A, Schmidt D et al (2007) MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors. J Magn Reson Imaging 26:1043–1052PubMedCrossRef Clasen S, Boss A, Schmidt D et al (2007) MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors. J Magn Reson Imaging 26:1043–1052PubMedCrossRef
43.
Zurück zum Zitat Laspas F, Sotiropoulou E, Mylona S et al (2009) Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications. J Gastrointestin Liver Dis 18:323–328PubMed Laspas F, Sotiropoulou E, Mylona S et al (2009) Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications. J Gastrointestin Liver Dis 18:323–328PubMed
44.
Zurück zum Zitat Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11:914–921PubMedCrossRef Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11:914–921PubMedCrossRef
45.
Zurück zum Zitat Gillams AR, Lees WR (2008) Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 19:712–717PubMedCrossRef Gillams AR, Lees WR (2008) Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 19:712–717PubMedCrossRef
46.
Zurück zum Zitat Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130PubMedCrossRef Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130PubMedCrossRef
47.
Zurück zum Zitat Camma C, Di Marco V, Orlando A et al (2005) Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42:535–540PubMedCrossRef Camma C, Di Marco V, Orlando A et al (2005) Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42:535–540PubMedCrossRef
48.
Zurück zum Zitat Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C (2003) Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 50:480–484PubMed Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C (2003) Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 50:480–484PubMed
49.
Zurück zum Zitat Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST (2008) Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12:183–191PubMedCrossRef Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST (2008) Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12:183–191PubMedCrossRef
Metadaten
Titel
MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions
verfasst von
Hansjörg Rempp
Lorenz Waibel
Rüdiger Hoffmann
Claus D. Claussen
Philippe L. Pereira
Stephan Clasen
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 9/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2438-x

Weitere Artikel der Ausgabe 9/2012

European Radiology 9/2012 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.